Search results
Results From The WOW.Com Content Network
Travoprost. Travoprost, sold under the brand name Travatan among others, is a medication used to treat high pressure inside the eye including glaucoma. [ 4] Specifically it is used for open angle glaucoma when other agents are not sufficient. [ 5][ 4] It is used as an eye drop. [ 4] Effects generally occur within two hours.
Netarsudil. Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. [ 1][ 2][ 3] In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular ...
Travoprost/timolol, sold under the brand name Duotrav among others, is a fixed-dose combination medication used for the treatment of glaucoma. It contains travoprost and timolol maleate. It was approved for medical use in the European Union in April 2006.
Timolol. Timolol is a beta blocker medication used either by mouth or as eye drops. [ 3][ 5] As eye drops it is used to treat increased pressure inside the eye such as in ocular hypertension and glaucoma. [ 3] By mouth it is used for high blood pressure, chest pain due to insufficient blood flow to the heart, to prevent further complications ...
(Reuters) - The U.S. Food and Drug Administration (FDA) on Wednesday warned consumers not to use unapproved eye drops that closely resemble Bausch + Lomb's Lumify product for redness relief.
[table-of-contents] stripped. It’s been a bad year for eye drops. The U.S. Food and Drug Administration (FDA) has issued yet another eye drop recall—this time focusing on 27 different over-the ...
Tafluprost. Tafluprost (trade names Taflotan by Santen Pharmaceutical, Zioptan by Merck in the US and Saflutan by Mundipharma in Australia) is a prostaglandin analogue. It is used topically (as eye drops) to control the progression of open-angle glaucoma and in the management of ocular hypertension, alone or in combination with other medication.
Twice daily in right eye 26 weeks 1.0% No mortality at all doses. After ocular administration, symptoms included hypermia of the bulbar and papebral conjunctiva, white spots in the lens. Dogs Once a day in right eye and orally 13 weeks 2.0% in eye, 7.5 mg/kg/day by mouth No mortality observed. Monkey Once a day in right eye 52 weeks 2.0%